Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

Mason, Neale S; Lopresti, Brian J; Ruszkiewicz, James; Dong, Xinxin; Joyce, Sonali; Leef, George; Sen, Malabika; Wahed, Abdus S; Mathis, Chester A; Grandis, Jennifer R; Thomas, Sufi M

Mason, Neale S; Lopresti, Brian J; Ruszkiewicz, James; Dong, Xinxin; Joyce, Sonali; Leef, George; Sen, Malabika; Wahed, Abdus S; Mathis, Chester A; Grandis, Jennifer R; Thomas, Sufi M.

Afiliação

Mason NS; Departments of Radiology, University of Pittsburgh and University of Pittsburgh Cancer Institute Pittsburgh, PA, USA.

Am J Nucl Med Mol Imaging ; 3(1): 16-31, 2013.

Article em En | MEDLINE | ID: mdl-23342298

Palavras-chave

2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG); 3'-[18F]Fluoro-3'-deoxythymidine ([18F]FLT); Squamous cell carcinoma of the head and neck (SCCHN); epidermal growth factor receptor (EGFR); positron emission tomography (PET); region of interest (ROI); standardize uptake values (SUV); volume of interest (VOI)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article